Cryptococcal meningitis management in Tanzania with strict schedule of serial lumber punctures using intravenous tubing sets: An operational research study

Journal of Acquired Immune Deficiency Syndromes

Volumn 66, Issue 2, 2014, Pages

  Meda, John ^a   Kalluvya, Samuel ^b,c   Downs, Jennifer A ^b,c,d   Chofle, Awilly A ^e   Seni, Jeremiah ^f   Kidenya, Benson ^f   Fitzgerald, Daniel W ^d   Peck, Robert N ^b,c,d  

^a UNIVERSITY OF DODOMA   (Tanzania)

^b Bugando Medical Centre   (Tanzania)

^c WEILL BUGANDO SCHOOL OF MEDICINE   (Tanzania)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e MUHIMBILI NATIONAL HOSPITAL   (Tanzania)

^f CATHOLIC UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

cryptococcal meningitis; HIV; intracranial pressure management; mortality; sub Saharan Africa; Tanzania

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; FLUCONAZOLE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE MONITORING; LUMBAR PUNCTURE; MALE; MORTALITY; PRIORITY JOURNAL; SPINAL FLUID MANOMETER; TANZANIA;

ADMINISTRATION, INTRAVENOUS; ADULT; ANTIFUNGAL AGENTS; DISEASE MANAGEMENT; FEMALE; FLUCONAZOLE; HIV INFECTIONS; HUMANS; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MALE; MENINGITIS, CRYPTOCOCCAL; OPERATIONS RESEARCH; PROSPECTIVE STUDIES; PUNCTURES; REGISTRIES; TANZANIA;

EID: 84901496076     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000147     Document Type: Article

References (24)

1. Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009;23:525-530.
2. Holmes CB, Losina E, Walensky RP, et al. Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. Clin Infect Dis. 2003;36:652-662. (Pubitemid 36259573)
3. Mallory KF, Churchyard GJ, Kleinschmidt I, et al. The impact of HIV infection on recurrence of tuberculosis in South African gold miners. Int J Tuberc Lung Dis. 2000;4:455-462. (Pubitemid 30256849)
4. Okongo M, Morgan D, Mayanja B, et al. Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda. Int J Epidemiol. 1998;27:698-702. (Pubitemid 28431516)
5. French N, Gray K, Watera C, et al. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS. 2002;16:1031-1038. (Pubitemid 34499426)
6. Jarvis JN, Boulle A, Loyse A, et al. High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out. AIDS. 2009;23:1182-1183.
7. Sloan DJ, Dedicoat MJ, Lalloo DG. Treatment of cryptococcal meningitis in resource limited settings. Curr Opin Infect Dis. 2009;22:455-463.
8. Leimann BCQ, Koifman RJ. Cryptococcal meningitis in Rio de Janeiro State, Brazil, 1994-2004. Cad Saude Publica. 2008;24:2582-2592.
9. Dromer F, Mathoulin-Pélissier S, Launay O, et al. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med. 2007;4:e21.
10. Van der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med. 1997;337:15-21.
11. Sloan D, Dlamini S, Paul N, et al. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resourcelimited settings. Cochrane Database Syst Rev. 2008;4:CD005647.
12. Wajanga BM, Kalluvya S, Downs JA, et al. Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study. J Int AIDS Soc. 2011;14:48.
13. Jackson A, Hosseinipour MC. Management of cryptococcal meningitis in sub-saharan Africa. Curr HIV/AIDS Rep. 2010;7:134-142.
14. Bicanic T, Brouwer AE, Meintjes G, et al. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS. 2009;23: 701-706.
15. Graybill JR, Sobel J, Saag M, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis. 2000;30:47-54. (Pubitemid 30067061)
16. Fessler RD, Sobel J, Guyot L, et al. Management of elevated intracranial pressure in patients with Cryptococcal meningitis. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:137-142.
17. The United Republic of Tanzania Ministry of Health and Social Welfare. National Guideline for the Management of HIV and AIDS. 4th ed. Dar es Salaam, Tanzania: 2012.
18. Nussbaum JC, Jackson A, Namarika D, et al. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi. Clin Infect Dis. 2010;50:338-344.
19. Jarvis JN, Govender N, Chiller T, et al. Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation. J Int Assoc Physicians AIDS Care (Chic). 2012;11: 374-379.
20. Rajasingham R, Meya DB, Boulware DR. Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care. J Acquir Immune Defic Syndr. 2012;59:e85-e91.
21. World Health Organization. Rapid Advice Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-infected Adults, Adolescents and Children. Geneva, Switzerland: 2011.
22. Loyse A, Dromer F, Day J, et al. Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal. J Antimicrob Chemother. 2013;68:2435-2444.
23. Loyse A, Thangaraj H, Easterbrook P, et al. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. Lancet Infect Dis. 2013;13:629-637.
24. Management Sciences for Health. International Drug Price Indicator Guide (2012). Available at: http://erc.msh.org/dmpguide. Accessed December 16, 2013.